Triclosan-coated sutures reduce wound infections after hepatobiliary surgery--a prospective non-randomized clinical pathway driven study

Langenbecks Arch Surg. 2011 Aug;396(6):845-50. doi: 10.1007/s00423-011-0786-7. Epub 2011 Apr 1.

Abstract

Objectives: Wound infections after abdominal surgery are still frequent types of nosocomial infections. Suture materials might serve as a vehicle for mechanical transport of bacteria into the surgical wound. To reduce bacterial adherence to surgical sutures, triclosan-coated polyglactin 910 suture materials with antiseptic activity (Vicryl plus®) were developed. The aim of this prospective non-randomized clinical pathway driven study was to ascertain if the use of Vicryl plus® reduced the number of wound infections after transverse laparotomy.

Patients and methods: Between October 2003 and October 2007, 839 operations were performed using a transverse abdominal incision. In the first time period, a PDSII® loop suture was used for abdominal wall closure. In the second time period, we used Vicryl plus®. Risk factors were collected prospectively to compare the two groups.

Results: Using a PDSII® loop suture for abdominal wall closure in the first time period, 9.2% of the patients developed wound infections. In the second time period, using Vicryl plus®, the number of wound infections decreased to 4.3% (p < 0,005). Both groups were comparable regarding risk factors despite no other changes in protocols of patient care.

Conclusion: Antiseptic-coated loop Vicryl suture for abdominal wall closure can be superior to PDSII sutures in respect to the development of wound infections after a two-layered closure of transverse laparotomy.

Publication types

  • Clinical Trial

MeSH terms

  • Abdomen / surgery*
  • Anti-Infective Agents, Local / pharmacology*
  • Antibiotic Prophylaxis
  • Critical Pathways
  • Female
  • Humans
  • Liver Diseases / surgery*
  • Logistic Models
  • Male
  • Middle Aged
  • Polyglactin 910
  • Prospective Studies
  • Risk Factors
  • Statistics, Nonparametric
  • Surgical Wound Infection / prevention & control*
  • Sutures*
  • Treatment Outcome
  • Triclosan / pharmacology*

Substances

  • Anti-Infective Agents, Local
  • Polyglactin 910
  • Triclosan